Skip to content

Kyverna Therapeutics, Inc. KYTX Prepaid & Other Current

Prepaid & Other Current at other companies

Gilead Sciences logo
Gilead SciencesGILD
$4.34B+53.5%
Climb Bio, Inc. logo
Climb Bio, Inc.CLYM
$3.84M+73.1%
Artiva Biotherapeutics, Inc. logo
Artiva Biotherapeutics, Inc.ARTV
$1.96M-48.6%
Iovance Biotherapeutics, Inc. logo
Iovance Biotherapeutics, Inc.IOVA
$12.93M-18.7%
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
$22.56M+9.5%
Vor Biopharma logo
Vor BiopharmaVOR
$6.39M+41.6%

Other financials

Income statement

See full
Operating income-$41.4M+12.7%
Net income-$39.7M+11.0%
EPS (diluted)-$0.66+35.9%

Balance sheet

See full
Cash & equivalents$32.2M-43.4%
Total debt$9.2M+32.1%
Total equity$195.6M-12.7%
Total assets$257.0M-1.4%

Cash flow

See full
Operating cash flow-$41.6M+7.4%
CapEx$2.0K-98.0%
Free cash flow-$33.5M+10.8%

Valuation

See full
Market cap$498.52M+276%
Enterprise value$475.49M+475%

Returns & leverage

See full
Return on equity-74.5%+74.4pp
Debt / equity0.0×
Current ratio8.1×+0.7×

Where this comes from

Reported directly by Kyverna Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.

The official record: Kyverna Therapeutics, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kyverna Therapeutics, Inc.'s prepaid & other current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Kyverna Therapeutics, Inc.'s prepaid & other current?
Kyverna Therapeutics, Inc. (KYTX) reported prepaid & other current of $5.28M in Q1 2026.
How has Kyverna Therapeutics, Inc.'s prepaid & other current changed year-over-year?
Kyverna Therapeutics, Inc.'s prepaid & other current increased by 5.6% year-over-year, from $5M to $5.28M.
What does prepaid & other current mean?
Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.